Sarah M. Poppler, MBA
About Sarah M. Poppler, MBA
Sarah M. Poppler, MBA, is a Senior Analyst at Boston Scientific, specializing in healthcare economics and market access analysis.
Title
Sarah M. Poppler, MBA, is a Senior Analyst at Boston Scientific, focusing on health economics and market access (HEMA) in Maple Grove, Minnesota.
Current Role at Boston Scientific
Since 2021, Sarah M. Poppler has been serving as a Senior Analyst in HEMA at Boston Scientific. In this role, she contributes to the strategic decision-making processes, leveraging her expertise in healthcare economics and market access analysis. She operates primarily from Maple Grove, Minnesota, and plays a key role in developing analytical models to assess the financial impact of healthcare policies and reimbursement strategies.
Previous Experience
Before joining Boston Scientific, Sarah Poppler accumulated extensive experience in healthcare analytics and financial consulting. She served as a Healthcare Analyst at Stella from 2018 to 2021 and a Data Analyst in Business Intelligence from 2017 to 2018. Additionally, she worked as a Healthcare Economic Consultant at UnitedHealth Group from 2016 to 2017 and held various analyst positions at Prime Therapeutics and UnitedHealth Group between 2011 and 2016.
Education and Expertise
Sarah M. Poppler holds an MBA from Capella University (2013-2015), a Bachelor of Science (BS) from Minnesota State University, Mankato (2008-2011), and an Associate of Arts (AA) from Ridgewater College (2006-2008). With expertise in healthcare economics and market access analysis, she has developed analytical models to understand financial impacts and participated in cross-functional teams to enhance data-driven decision-making processes in the healthcare sector.